Bracht, T.; Kleefisch, D.; Schork, K.; Witzke, K.E.; Chen, W.; Bayer, M.; Hovanec, J.; Johnen, G.; Meier, S.; Ko, Y.-D.;
et al. Plasma Proteomics Enable Differentiation of Lung Adenocarcinoma from Chronic Obstructive Pulmonary Disease (COPD). Int. J. Mol. Sci. 2022, 23, 11242.
https://doi.org/10.3390/ijms231911242
AMA Style
Bracht T, Kleefisch D, Schork K, Witzke KE, Chen W, Bayer M, Hovanec J, Johnen G, Meier S, Ko Y-D,
et al. Plasma Proteomics Enable Differentiation of Lung Adenocarcinoma from Chronic Obstructive Pulmonary Disease (COPD). International Journal of Molecular Sciences. 2022; 23(19):11242.
https://doi.org/10.3390/ijms231911242
Chicago/Turabian Style
Bracht, Thilo, Daniel Kleefisch, Karin Schork, Kathrin E. Witzke, Weiqiang Chen, Malte Bayer, Jan Hovanec, Georg Johnen, Swetlana Meier, Yon-Dschun Ko,
and et al. 2022. "Plasma Proteomics Enable Differentiation of Lung Adenocarcinoma from Chronic Obstructive Pulmonary Disease (COPD)" International Journal of Molecular Sciences 23, no. 19: 11242.
https://doi.org/10.3390/ijms231911242
APA Style
Bracht, T., Kleefisch, D., Schork, K., Witzke, K. E., Chen, W., Bayer, M., Hovanec, J., Johnen, G., Meier, S., Ko, Y. -D., Behrens, T., Brüning, T., Fassunke, J., Buettner, R., Uszkoreit, J., Adamzik, M., Eisenacher, M., & Sitek, B.
(2022). Plasma Proteomics Enable Differentiation of Lung Adenocarcinoma from Chronic Obstructive Pulmonary Disease (COPD). International Journal of Molecular Sciences, 23(19), 11242.
https://doi.org/10.3390/ijms231911242